Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 16 (5) , 595-599
- https://doi.org/10.1097/00019052-200310000-00005
Abstract
PURPOSE OF REVIEW: Many forms of spinal muscular atrophy, a pure lower motor neuron disease, have been characterized clinically but the molecular basis of most of these is unknown. In this article we review recent developments in our understanding of the spinal muscular atrophies and how this knowledge has revealed important new insights into the causes of motor neuron vulnerability which may ultimately lead to novel therapies for this untreatable group of disorders. RECENT FINDINGS: The identification of the genetic basis of two forms of autosomal recessive spinal muscular atrophy has revealed that lower motor neurons appear to have a specific vulnerability to defects in RNA metabolism. Most notably, the survival motor neuron protein, deficient in the most common form of spinal muscular atrophy, plays a multifunctional role in ribonucleoprotein metabolism and pre-messenger RNA splicing. The role of this protein in motor neurons is currently under intense study. The identification of two other spinal muscular atrophy-causing genes has provided support for the central role of components of the RNA metabolic pathway in determining motor neuron survival. SUMMARY: Understanding the molecular basis of lower motor neuron vulnerability in disorders such as spinal muscular atrophy will ultimately allow these disabling disorders to be treated. In addition we can expect to learn much about basic neuronal biology and about the pathways that are relevant to more common neurodegenerative disorders such as amyotrophic lateral sclerosisKeywords
This publication has 38 references indexed in Scilit:
- Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathyNeurology, 2003
- The Predictive Value of Achieved Motor Milestones Assessed in 441 Patients with Infantile Spinal Muscular Atrophy Types II and IIIEuropean Neurology, 2001
- Disruption of SMN function by ectopic expression of the human SMN gene in DrosophilaFEBS Letters, 2000
- Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) proteinHuman Molecular Genetics, 2000
- The Caenorhabditis Elegans Orthologue of the Human Gene Responsible for Spinal Muscular Atrophy Is a Maternal Product Critical for Germline Maturation and Embryonic ViabilityHuman Molecular Genetics, 1999
- A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2Human Molecular Genetics, 1999
- Quantitative Analysis of Survival Motor Neuron Copies: Identification of Subtle SMN1 Mutations in Patients with Spinal Muscular Atrophy, Genotype-Phenotype Correlation, and Implications for Genetic CounselingAmerican Journal of Human Genetics, 1999
- Genomic Variation and Gene Conversion in Spinal Muscular Atrophy: Implications for Disease Process and Clinical PhenotypeAmerican Journal of Human Genetics, 1997
- Identification and characterization of a spinal muscular atrophy-determining geneCell, 1995
- Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.Journal of Medical Genetics, 1978